5-Bromo-4-chlorothieno[2,3-d]pyrimidine

Catalog No. :
ACWHKB895
CAS No. :
814918-95-1
Molecular Formula :
C6H2BrClN2S
Molecular Weight :
249.52

IUPAC Name:5-bromo-4-chlorothieno[2,3-d]pyrimidine

5-Bromo-4-chlorothieno[2,3-d]pyrimidine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$81.00Login to see priceIn stockInquiry
5g95%$397.00Login to see priceIn stockInquiry
25g95%$1477.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-Bromo-4-chlorothieno[2,3-d]pyrimidine
IUPAC Name5-bromo-4-chlorothieno[2,3-d]pyrimidine
MDL No.MFCD11042739
Molecular FormulaC6H2BrClN2S
Molecular Weight249.52
SMILESClC1=C(C(Br)=CS2)C2=NC=N1
InChI KeyIKCKRHCJPVDELP-UHFFFAOYSA-N
Synonym5-bromo-4-chlorothieno[2,3-d]pyrimidine;5-BroMo-4-chlorothieno[2,...;Thieno[2,3-d]pyrimidine, 5-bromo-4-chloro-;5-bromo-4-chlorothieno[2,3-d]pyrimidine ISO 9001:2015 REACH;5-bromo-4-chlorothienol [2, 3-d] pyrimidine
CAS No.814918-95-1
PubChem CID45480299

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302
Precautionary Statement(s)
P280-P305+P351+P338

Synthetic Route by SureRoute

1. ACWHKB895 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACCGBV074 route compound structure diagram
    ACCGBV0741239460-83-3 In Stock
  4. Then
  5. ACWHKB895 route product structure diagram
    ACWHKB895814918-95-1 In Stock
Inquiry

2. ACWHKB895 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACCGBV074 route compound structure diagram
    ACCGBV0741239460-83-3 In Stock
  4. Plus
  5. reactant_3 route compound structure diagram
    --
  6. Then
  7. ACWHKB895 route product structure diagram
    ACWHKB895814918-95-1 In Stock
Inquiry

Comments (0)